Press | Mayo Clinic Business Development

Latest news

nference launches real-world data platform, expands Mayo Clinic partnership

MobiHealthNews | September 21, 2022

Mayo Clinic, Hibiscus BioVentures and Innoforce announce Mayflower cell and gene therapy accelerator

Mayo Clinic News Network | August 31, 2022

Castle Creek Biosciences announces publication of preclinical study for potential in vivo gene therapy in Nature Communications

PR Newswire | August 30, 2022

Genomadix Inc. announces know-how license agreement with Mayo Clinic

PR Newswire | August 29, 2022

Mayo Clinic announces a strategic collaboration for a new era of biomanufacturing

Mayo Clinic News Network | August 15, 2022

Diagnostic Robotics raises $45M Series B

Mass Device | August 1, 2022

EXCERPT: Mayo Clinic participated, making the Israel-based firm a Mayo Clinic portfolio company.

Light Line Medical enters into know-how license agreement with Mayo Clinic

Business Wire | July 20, 2022

Lisa Health launches Midday, an app leveraging AI to personalize the menopause journey, in collaboration with Mayo Clinic

Mayo Clinic News Network | July 19, 2022

Novartis links up with Mayo Clinic spinout Anumana to develop ECG-reading AI

Fierce Biotech | July 14, 2022

VeriSIM Life enters into collaboration agreement with Mayo Clinic to jointly advance drug discovery and development programs

Business Wire | June 28, 2022

Turtle Health to collaborate with Mayo Clinic to bring gynecology care to patients’ homes

PR Newswire | June 21, 2022

Mayo Clinic, Médica Sur expand relationship to advance cancer care

Mayo Clinic News Network | June 21, 2022

Mayo Clinic, K Health team up to use AI for personalized hypertension treatment

Fierce Healthcare | June 20, 2022

Anumana wins FDA breakthrough nod for AI algorithm that detects pulmonary hypertension

Mass Devices | May 24, 2022

EXCERPT: The algorithm is Anumana’s second to receive a breakthrough nod, with its low ejection fraction algorithm (developed by Mayo Clinic and licensed by Anumana) garnering approval in 2019, plus FDA emergency use authorization (EUA) for COVID-19 in 2020.

Mayo Clinic buys minority stake in Karkinos Healthcare

Mayo Clinic News Network | May 23, 2022

Rochester startup Vyriad developing cancer-fighting viruses

Star Tribune | May 17, 2022

EXCERPT: The company, an outgrowth of Mayo Clinic, recently raised more money from investors as it seeks new ways to treat cancer

Vyriad, Inc. raises $29.5M in Series B funding led by renowned genetics entrepreneur

PR Newswire | May 17, 2022

Mayo Clinic researchers use AI to detect weak heart pump via patients’ Apple Watch ECGs

Mayo Clinic News Network | May 2, 2022

EXCERPT: Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic effectively identified patients with a weak heart pump.

KLOC Health enters into know-how agreement with Mayo Clinic for health staffing platform

PR Newswire | April 14, 2022

Pramana launches digital pathology as a service platform, offering comprehensive and scalable glass slide digitization for health systems

Business Wire | March 16, 2022

EXCERPT: Pramana’s first commercial agreement with Mayo Clinic is a multi-year collaboration that includes an industry-leading initiative to digitize 5 million slides – one of the largest digitization efforts in the world to date, at an unprecedented rate.

OpenDNA announces know-how and research agreement with Mayo Clinic as part of pilot clinical study for cardiovascular disease prevention

Medgadget | March 9, 2022

St. Jude founder and Minnesota med tech trailblazer is driven by heart

Star Tribune | February 7, 2022

EXCERPT: The company [Medical21] is collaborating with Mayo Clinic, which owns an equity stake in the company. Juan Crestanello, a cardiovascular surgeon at Mayo, said he and his colleagues have seen some of Medical 21’s work. “The results, so far, have been very encouraging,” Crestanello said.

Pathogenomix granted FDA Breakthrough Device Designation

PR Newswire | January 19, 2022

EXCERPT: Pathogenomix, Inc. collaborated with Mayo Clinic on the development of the techniques and data which supported the application for this FDA Breakthrough Device Designation.

Baxter, Cardinal Health join Mayo, Kaiser with $110 million stake in ‘hospital care at home’ venture

Forbes | January 10, 2022

LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases

PR Newswire | January 6, 2022

NaNotics to collaborate with Mayo Clinic on nanomedicine cancer treatment

Business Wire | January 4, 2022

Mesuron Inc. announces know-how license agreement and stock purchase agreement with Mayo Clinic

Globe Newswire | January 4, 2022

Two Discovery Square to open for next wave of biotech collaboration with Mayo Clinic

Star Tribune | December 23, 2021

EXCERPT: “We anticipate that we’ll have relationship with pretty much every company in Two Discovery Square,” said Dr. Clark Otley, medical director of the Department of Business Development at Mayo Clinic.